Showing results (81-90 of 301) with videos related to
Sort By:
Pageof 31
AIDS (London, England)|September 22, 2006
Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibodySusanne Johansson, David M Goldenberg, Gary L Griffiths, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Combining milatuzumab with bortezomib, doxorubicin, or dexamethasone improves responses in multiple myeloma cell linesRhona Stein, Mitchell R Smith, Susan Chen, et al.Biotechnology Progress|April 8, 2011
A new mammalian host cell with enhanced survival enables completely serum-free development of high-level protein production cell linesDiane L Rossi, Edmund A Rossi, David M Goldenberg, et al.Cancer Biotherapy & Radiopharmaceuticals|May 5, 2009
Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody capM Jules Mattes, Rosana B Michel, David M Goldenberg, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 6, 2011
The radiolabeling of proteins by the [18F]AlF methodWilliam J McBride, Christopher A D'Souza, Robert M Sharkey, et al.Bioconjugate Chemistry|November 3, 2012
Optimization of multivalent bispecific antibodies and immunocytokines with improved in vivo propertiesEdmund A Rossi, Chien-Hsing Chang, Thomas M Cardillo, et al.International Journal of Cancer|April 4, 2003
Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrenceAlice P Taylor, Marisol Rodriguez, Kelly Adams, et al.BMC Cancer|April 4, 2013
Targeting both IGF-1R and mTOR synergistically inhibits growth of renal cell carcinoma in vitroThomas M Cardillo, Preeti Trisal, Roberto Arrojo, et al.Update on Cancer Therapeutics|March 4, 2008
Cancer Imaging and Therapy with Bispecific Antibody PretargetingDavid M Goldenberg, Jean-Francois Chatal, Jacques Barbet, et al.Seminars in Oncology|August 27, 2003
CD22-directed monoclonal antibody therapy for lymphomaAbby B Siegel, David M Goldenberg, Alessandra Cesano, et al.Pageof 31